Search clinical trials for: low-grade glioma

Total 3191 results

Case Comprehensive Cancer Center
National Cancer Institute (NCI)

Completed

High Light and Low Light Dose PDT in Glioma

Brain and Central Nervous System Tumors

United States
Case Comprehensive Cancer Center
National Cancer Institute (NCI)

Terminated

Gene Therapy and Chemotherapy in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma

Lymphoma | Brain and Central Nervous System Tumors | Unspecified Adult Solid Tumor, Protocol Specific

United States
Rigshospitalet, Denmark
Wyeth is now a wholly owned subsidiary of Pfizer; University of Copenhagen; Roche...

Completed

A Study of Temsirolimus and Bevacizumab in Recurrent Glioblastoma Multiforme

Glioblastoma Multiforme

Denmark
Dana-Farber Cancer Institute
Massachusetts General Hospital; Beth Israel Deaconess Medical Center; Brigham... and other collaborators

Completed

Study of Lenalidomide and XRT in Patients With Newly Diagnosed Glioblastoma Multiforme

Glioblastoma | Gliosarcoma | Malignant Gliomas

United States
Medanta Institute of Clinical Research

Unknown

A Comparison of FDG-PET Versus MRI Based Target Volume Delineation in Glioblastoma and the Role of FDG-PET/CT in the Alteration of MRI Based Target Volumes.

Glioblastoma
Envita Medical Center, Inc.

Suspended

Safety and Effectiveness Study of Autologous Natural Killer and Natural Killer T Cells on Cancer

Glioma | Breast Cancer | Pancreatic Cancer | Prostate Cancer | Colon Cancer | Hepatocellular Cancer | Squamous Cell Lung Cancer

United States
Kentuckiana Cancer Institute
DR. Kathleen Egan

Completed

Genetic Epidemiology of Adult Onset Glioma

Adult-Onset Glioma

United States
Kentuckiana Cancer Institute
Eisai Inc.

Unknown

A Phase II Study Of Gliadel, Concomitant Temozolomide And Radiation, Followed By Dose Dense Therapy With Temozolomide Plus Bevacizumab For Newly Diagnosed Malignant High Grade Glioma (KARE004)

Glioma

United States
Kentuckiana Cancer Institute

Completed

High Dose Camptothecin-11 (CPT-11) in Recurrent Unresectable Malignant Glioma

Malignant Glioma

United States
Kentuckiana Cancer Institute
Eisai Inc.

Unknown

A Phase II Study of Gliadel, Concomitant Temozolomide and Radiation, Followed By Dose Dense Therapy With Temozolomide For Newly Diagnosed Malignant High Grade Glioma (KARE003)

Glioma

United States
National Taiwan University Hospital

Withdrawn

Photodynamic Therapy in the Treatment of Malignant Intracranial Tumors

Glioblastoma Multiforme | Anaplastic Ependymoma | Anaplastic Astrocytomas | Anaplastic Oligodendrogliomas | Malignant Intracranial Tumors

Taiwan
Thallion Pharmaceuticals

Terminated

Efficacy Study of TLN-4601 in Patients With Recurring Glioblastoma Multiforme

Glioblastoma Multiforme

United States, Canada
AstraZeneca

Completed

Phase I : Cediranib in Combination With Lomustine Chemotherapy in Recurrent Malignant Brain Tumour

Brain Tumor | Recurrent Glioblastoma

United States, United Kingdom
National Institute of Neurology and Neurosurgery...

Completed

Chloroquine for Treatment of Glioblastoma Multiforme

Glioblastoma Multiforme

Mexico
Pediatric Brain Tumor Consortium
National Cancer Institute (NCI)

Terminated

TP-38 Toxin in Treating Young Patients With Recurrent or Progressive Supratentorial High-Grade Glioma

Brain and Central Nervous System Tumors

United States
Pediatric Brain Tumor Consortium
National Cancer Institute (NCI)

Terminated

Carmustine Implants and O(6)-Benzylguanine in Treating Children With Recurrent Malignant Glioma

Brain and Central Nervous System Tumors

United States
Pediatric Brain Tumor Consortium
National Cancer Institute (NCI)

Completed

Oxaliplatin in Treating Children With Recurrent or Refractory Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Atypical Teratoid Rhabdoid Tumor

Brain and Central Nervous System Tumors

United States
Pediatric Brain Tumor Consortium
National Cancer Institute (NCI)

Completed

SCH 66336 in Treating Children With Recurrent or Progressive Brain Tumors

Brain and Central Nervous System Tumors

United States
Pediatric Brain Tumor Consortium
National Cancer Institute (NCI)

Terminated

SU5416 in Treating Children With Recurrent or Progressive Brain Tumors

Brain and Central Nervous System Tumors

United States
Duke University

Completed

Carboplatin in Patients With Progressive Gliomas

Brain and Central Nervous System Tumors

United States, Canada
Orion Corporation, Orion Pharma

Completed

Effect of Moisturising Creams on Skin Moisture in Atopic Dermatitis

Dermatitis, Atopic

Finland
Pediatric Brain Tumor Consortium
National Cancer Institute (NCI)

Completed

Busulfan in Treating Children and Adolescents With Refractory CNS Cancer

Sarcoma | Lymphoma | Leukemia | Brain and Central Nervous System Tumors | Metastatic Cancer | Retinoblastoma | Childhood Germ Cell Tumor

United States
Methodist Healthcare

Terminated

Radiation Boost for Newly Diagnosed Glioblastoma Multiforme

Glioblastoma Multiforme

United States
Methodist Healthcare

Terminated

Gliadel Wafer, Temozolomide and Radiation Therapy for Newly Diagnosed GBM

Glioblastoma Multiforme | High-Grade Glioma

United States
Tel-Aviv Sourasky Medical Center

Unknown

Comparison of Neuro-navigational Systems for Resection-Control of Brain Tumors

Glioma

Israel
Teva Pharmaceuticals USA

Completed

Famciclovir 500 mg Tablets Under Non-Fasting Conditions

Healthy

United States, Canada
Gustave Roussy, Cancer Campus, Grand Paris

Completed

Safety Study of Tarceva in Children With Refractory and Relapsed Malignant Brain Tumors and Newly Diagnosed Brain Stem Glioma

Malignant Brain Tumor | Brain Stem Glioma,

France
Gustave Roussy, Cancer Campus, Grand Paris

Completed

Clinical Studies of Gemcitabine-Oxaliplatin

Osteosarcoma | Medulloblastoma | Neuroblastoma | Central Nervous System Tumors

France
University of Regensburg
Essex Pharma Germany

Completed

Pegylated Liposomal Doxorubicine and Prolonged Temozolomide in Addition to Radiotherapy in Newly Diagnosed Glioblastoma

Glioblastoma

Germany
TransMolecular

Unknown

A Study of 131I-TM601 in Adults With Recurrent Malignant Glioma

Astrocytoma | Glioblastoma Multiforme | Malignant Glioma | GBM | Oligodendroglioma

United States
TransMolecular

Unknown

Safety and Dose-Finding Study of TM-601 in Adults With Recurrent Malignant Glioma

Astrocytoma | Glioblastoma Multiforme | Malignant Glioma | GBM | Oligodendroglioma

United States
Sigma-Tau Research, Inc.
Rhode Island Hospital

Completed

This is an Early Study to Investigate the Effect of Gimatecan® in Adults With Malignant Glioma.

Malignant Glioma

United States
Bradmer Pharmaceuticals Inc.

Unknown

Neuradiab® Combined With Bevacizumab (Avastin) Therapy in Patients With Recurrent Glioblastoma Multiforme

Brain Tumors

United States
Millennium Pharmaceuticals, Inc.

Withdrawn

Safety Study of the Combination of Tandutinib With Temozolomide and Bevacizumab After Radiation and Temozolomide in Patients With Newly Diagnosed With Glioblastoma Multiforme

Glioblastoma Multiforme
Stanford University
CTI BioPharma; Cephalon

Completed

Phase I Trial of Arsenic Trioxide and Stereotactic Radiotherapy for Recurrent Malignant Glioma

Brain Cancer

United States
TransMolecular

Unknown

131-I-TM-601 Study in Adults With Recurrent High-Grade Glioma

Glioblastoma Multiforme | Malignant Glioma | Gliosarcoma | GBM | Anaplastic Astrocytoma | Oligo-Astrocytoma

United States
Pharmacyclics LLC.

Completed

A Study of Motexafin Gadolinium and Temozolomide for the Treatment of Malignant Gliomas

Glioma | Glioblastoma | Astrocytoma | Brain Neoplasm | Oligodendroglioma

United States
TransMolecular

Completed

131-I-TM-601 Study in Adults With Solid Tumors

Glioma | Melanoma | Breast Cancer | Colorectal Cancer | Pancreatic Cancer | Non-Small Cell Lung Cancer | Prostate Adenocarcinoma | Primary Solid Tumors

United States
TransMolecular

Completed

Safety and Tolerability Study of 131I-TM-601 to Treat Adult Patients With Recurrent Glioma.

Glioma | Brain Neoplasm

United States
National Cancer Institute (NCI)

Completed

Carmustine in Treating Patients With Recurrent Malignant Glioma

Brain and Central Nervous System Tumors

United States
National Cancer Institute (NCI)

Completed

Brachytherapy in Treating Patients With Recurrent Malignant Glioma

Brain and Central Nervous System Tumors

United States
National Cancer Institute (NCI)

Completed

O6-Benzylguanine and Carmustine Implants in Treating Patients With Recurrent Malignant Glioma

Brain and Central Nervous System Tumors

United States
Weill Medical College of Cornell University

Suspended

Biological Therapy in Treating Patients With Primary or Advanced Glioma

Brain and Central Nervous System Tumors

United States
National Cancer Institute (NCI)

Completed

Gene Therapy in Treating Patients With Recurrent or Progressive Brain Tumors

Brain and Central Nervous System Tumors
National Cancer Institute (NCI)

Completed

Surgery Followed by Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Brain and Central Nervous System Tumors

United States
Jonsson Comprehensive Cancer Center
National Cancer Institute (NCI)

Completed

Motexafin Gadolinium Plus Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Brain and Central Nervous System Tumors

United States
Peregrine Pharmaceuticals

Completed

Radiolabeled Monoclonal Antibody in Treating Patients With Glioblastoma Multiforme or Anaplastic Astrocytoma

Brain and Central Nervous System Tumors

United States
National Cancer Institute (NCI)

Completed

Motexafin Gadolinium in Treating Patients With Glioblastoma Multiforme Who Are Undergoing Radiation Therapy to the Brain

Brain and Central Nervous System Tumors

United States
Siemens Molecular Imaging

Completed

Exploratory, Phase 0 Study of Positron Emission Tomography (PET) Imaging Agent, F-18 RGD-K5 (K5)

Melanoma | Sarcoma | Breast Cancer | Lung Cancer | High Grade Gliomas

United States
Boneca Corporation

Completed

BNCT to Treat Glioma That Has Progressed Following Radiotherapy

Glioblastoma | Anaplastic Astrocytoma

Finland

Search clinical trials for: low-grade glioma

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Zambia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations